| SP Thoracic IDE Study (NCT05150210) | Intuitive Surgical | 2022-07-20 |
| A Study of Nipocalimab in Children Aged 2 to Less Than 18 Years With Generalized Myasthenia Gravis (NCT05265273) | Janssen Research & Development, LLC | 2022-07-20 |
| Interleukin and Autoantibodies in Myasthenia Gravis. (NCT05301153) | Assiut University | 2022-07-01 |
| Evaluate the Safety of HBM9161 (HL161) Subcutaneous Injection in Patients With Generalized Myasthenia Gravis (NCT05332210) | Harbour BioMed (Guangzhou) Co. Ltd. | 2022-06-30 |
| The Effectiveness of Bu Zhong Yi Qi Tang in Patients with Myasthenia Gravis (NCT06881173) | Cheng, yu-ting | 2022-06-14 |
| Sensitivity of Repetitive Nerve Stimulation Performed in the Evening vs in the Morning in Myasthenia Gravis (NCT05337891) | Jagiellonian University | 2022-06-03 |
| Acupuncture in Myasthenia Gravis (AcuMG) (NCT05230082) | HealthPartners Institute | 2022-05-25 |
| Biomarkers for Fatigue in Patients with Myasthenia Gravis (NCT06860347) | Leiden University Medical Center | 2022-05-19 |
| Study of ALXN2050 in Adult Participants With Generalized Myasthenia Gravis (NCT05218096) | Alexion Pharmaceuticals, Inc. | 2022-04-27 |
| Diaphragm Thickness by Ultrasonography in Neurological Disorders (NCT05324176) | Mansoura University | 2022-04-13 |
| Predictors of Myasthenia Gravis Outcome Following Thoracoscopic Thymectomy: Comparative Study Between Thymomatous and Non-Thymomatous Patients (NCT07319689) | Tanta University | 2022-01-01 |
| Predictors and Prognostic Factors of Myasthenia Gravis Outcome (NCT05214612) | Assiut University | 2022-01-01 |
| Efficacy and Safety of Tolebrutinib (SAR442168) Tablets in Adult Participants With Generalized Myasthenia Gravis (NCT05132569) | Sanofi | 2021-12-03 |
| Exercise in Autoimmune Myasthenia Gravis and Myasthenic Syndromes (NCT05408702) | Institut de Myologie, France | 2021-11-12 |
| Immune Profiles in Myasthenia Gravis (NCT05095103) | University of Manchester | 2021-10-01 |
| Evaluate the Efficacy and Safety of HBM9161(HL161)Subcutaneous Injection in Patients With Generalized MG Patients (NCT05039190) | Harbour BioMed (Guangzhou) Co. Ltd. | 2021-09-25 |
| Influences of Sugammadex on Postoperative Progress in Patients With Myasthenia Gravis Undergoing Video-assisted Thoracoscopic Thymectomy: Retrospective Study (NCT05694234) | Yonsei University | 2021-09-01 |
| The Adapting Disease Specific Outcome Measures Pilot Trial for Telehealth in Myasthenia Gravis (NCT05917184) | Yale University | 2021-08-30 |
| A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis (NCT04951622) | Janssen Research & Development, LLC | 2021-07-15 |
| Clinical Trial Comparing Two Non-Surgical Treatments for Severe Blepharoptosis (NCT04678115) | Massachusetts Eye and Ear Infirmary | 2021-06-01 |
| Exploring Outcomes and Characteristics of Myasthenia Gravis 2 (NCT06002945) | Yale University | 2021-01-12 |
| Tacrolimus Combined With Low-dose Prednisone for Treatment of Myasthenia Gravis (NCT04768465) | Da, Yuwei, M.D. | 2021-01-01 |
| Medication Adherence and Non-adherence in Adults With Rare Disease (NCT04541875) | Xperiome | 2021-01-01 |
| A Prospective Cohort Study Of Myasthenia Gravis (NCT04674605) | First Affiliated Hospital of Chongqing Medical University | 2020-12-31 |
| Artificial Intelligence for the Analysis of Video Data of Facial Movement, with a Focus on Myasthenia Gravis (NCT06860360) | Leiden University Medical Center | 2020-12-01 |
| National, Multicentric Registry Study on Neuroimmunological Diseases in China (NCT06443333) | Xuanwu Hospital, Beijing | 2020-12-01 |
| Myasthenia Gravis Inebilizumab Trial (NCT04524273) | Amgen | 2020-10-15 |
| Help Build an A.I. Model to Predict Myasthenia Gravis Symptom Patterns and Flares (NCT04590716) | doc.ai inc | 2020-10-02 |
| Study of Myasthenic Crisis in China (NCT04837625) | Huashan Hospital | 2020-10-01 |
| Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous System (NCT04561557) | Tongji Hospital | 2020-09-22 |
| Subcutaneous Immunoglobulin for Myasthenia Gravis (NCT04728425) | University Health Network, Toronto | 2020-08-28 |
| A Study to Evaluate the Efficacy, Safety and PD and PK of HBM9161 in MG Patients (NCT04346888) | Harbour BioMed (Guangzhou) Co. Ltd. | 2020-07-23 |
| Efficacy of Apraclonidine Eye Drops in the Treatment of Ptosis Secondary to Myasthenia Gravis (NCT05045248) | American University of Beirut Medical Center | 2020-06-01 |
| Follow-up of a Cohort of Patients With Myasthenic Syndrome and COVID-19 Infection (NCT04695379) | University Hospital, Bordeaux | 2020-04-27 |
| Influence of Minimally Invasive Thymectomy on the Subsequent Clinical Course of Myasthenia Gravis (NCT04158661) | Charite University, Berlin, Germany | 2020-04-20 |
| A Pilot Study to Explore the Role of Gut Flora in Myasthenia Gravis (NCT04224506) | ProgenaBiome | 2020-03-02 |
| A Study of TAK-079 in People With Generalized Myasthenia Gravis (NCT04159805) | Takeda | 2020-01-14 |
| The Impact of Myasthenia Gravis in the Real World (NCT04176211) | Vitaccess Ltd | 2019-12-12 |
| Can Interval Walking Influence on Fatigue in the Danish Cohort of Myasthenia Gravis Patients (NCT03900585) | Rigshospitalet, Denmark | 2019-08-01 |
| Physical Activity and Fatigue in Myasthenia Gravis (NCT03905473) | Rigshospitalet, Denmark | 2019-06-01 |
| Burden of Disease in Myasthenia Gravis (NCT03979521) | Charite University, Berlin, Germany | 2019-05-01 |
| Beta-agonist Efficacy and Tolerability as Adjuvant Therapy in Myasthenia Gravis (NCT03914638) | University of Aarhus | 2019-04-01 |
| Rhythmic Auditory Stimulation and Walking Speed in the 6-minute Walk Test (NCT03905161) | Rigshospitalet, Denmark | 2019-02-10 |
| Clinical Trial to Improve the Magnetic Levator Prosthesis (NCT03818204) | Massachusetts Eye and Ear Infirmary | 2019-02-07 |
| Neurology Inpatient Clinical Education Trial (NCT03826056) | Dartmouth-Hitchcock Medical Center | 2019-02-01 |
| A Phase 3 Open-Label Study of Eculizumab in Pediatric Participants With Refractory Generalized Myasthenia Gravis (gMG) (NCT03759366) | Alexion Pharmaceuticals, Inc. | 2018-12-28 |
| The Effect of Spinal Stabilization Exercises in Patients With Myasthenia Gravis (NCT03743740) | Hacettepe University | 2018-12-03 |
| The Curative Effect of Extended Thymectomy Performed Through Subxiphoid-right VATS Approach With Elevation of Sternum (NCT03613272) | Jiang Fan | 2018-07-01 |
| Effect of Pyridostigmine (Mestinon) on Muscle Strength in Myasthenia Gravis (NCT03510546) | University of Aarhus | 2018-04-09 |
| Interval Inspiratory Training and Aerobic Exercise for Muscle Recovery in Myasthenia Gravis Post-Hospitalization (NCT06624345) | Chang Gung University | 2018-01-01 |
| Study to Test the Safety, Tolerability and Efficacy of UCB7665 in Subjects With Moderate to Severe Myasthenia Gravis (NCT03052751) | UCB Biopharma S.P.R.L. | 2017-05-15 |
| Myasthenia Gravis and Psyche (NCT03205306) | Charite University, Berlin, Germany | 2017-05-08 |
| Trial of Orencia in Patients With Myasthenia Gravis (NCT03059888) | Johns Hopkins University | 2017-04-12 |
| Pregnancy Registry, Infants, Serum/Milk Analysis (PRISMA) (NCT06940323) | University of California, San Francisco | 2017-03-21 |
| Clinical Prognosis and Progression of Myasthenia Gravis Patients (NCT04101578) | Da, Yuwei, M.D. | 2017-02-08 |
| Variables Predicting Reintubation After Thymectomy in Patients With Myasthenia Gravis (NCT03597373) | First Affiliated Hospital, Sun Yat-Sen University | 2017-01-01 |
| A Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of ARGX-113 in Patients With Myasthenia Gravis Who Have Generalized Muscle Weakness (NCT02965573) | argenx | 2016-12-30 |
| Biomarkers in Neural Disorders (NCT02761707) | University of Pennsylvania | 2016-06-01 |
| The EXPLORE MG Registry for Myasthenia Gravis (NCT03792659) | Yale University | 2016-03-30 |
| Safety, Tolerability and Immunogenic Response of CV-MG01 in Patients With Myasthenia Gravis (NCT02609022) | CuraVac | 2016-03-01 |
| Pilot Study: Use of the Saccadometer to Detect Characteristic Saccadic Peak Velocity in Myasthenia Gravis Patients (NCT06501794) | University of Liverpool | 2016-03-01 |
| Univent Tube for Thoracoscopic Thymectomy in Myasthenic Patients (NCT06101407) | Nguyen Dang Thu | 2016-01-15 |
| Tissue Repository for Studies of Myasthenia Gravis (NCT02902536) | Johns Hopkins University | 2015-08-01 |
| Efficacy and Safety of IGIV-C in Corticosteroid Dependent Patients With Generalized Myasthenia Gravis (NCT02473965) | Grifols Therapeutics LLC | 2015-06-01 |
| Open Label Study of Subcutaneous Immunoglobulin (SCIg) in Myasthenia Gravis (NCT02100969) | Mazen Dimachkie, MD | 2015-05-01 |
| A Pilot Trial To Assess The Feasibility And Efficacy Of SCIG In Patients With MG Exacerbation (SCIG-MG) (NCT02774239) | University of Alberta | 2014-10-01 |
| Benefits and Tolerance of Exercise in Patients With Generalized and Stabilized Myasthenia Gravis (NCT02066519) | Assistance Publique - Hôpitaux de Paris | 2014-10-01 |
| Therapy of Antibody-mediated Autoimmune Diseases by Bortezomib (TAVAB) (NCT02102594) | Charite University, Berlin, Germany | 2014-10-01 |
| The Safety and Efficacy of "3-Hole" Subxiphorid Approach in the Treatment of Anterior Mediastinal Tumor (NCT02317224) | Tang-Du Hospital | 2014-08-01 |
| Translation, Cross-cultural Adaptation and Validation of the MGQOL-15-F (NCT02470364) | Assistance Publique - Hôpitaux de Paris | 2014-06-01 |
| BeatMG: Phase II Trial of Rituximab In Myasthenia Gravis (NCT02110706) | Yale University | 2014-05-01 |
| Innovative Measures of Speech and Swallowing Dysfunction in Neurological Disorders (NCT02118805) | Beth Israel Deaconess Medical Center | 2013-10-01 |
| Therapeutic Plasma Exchange in MG (NCT01927692) | Duke University | 2013-07-01 |
| The Efficacy and Safety of Leflunomide or Azathioprine Therapy in Myasthenia Gravis Patients After Expand Thymectomy (NCT01727193) | First Affiliated Hospital, Sun Yat-Sen University | 2012-09-01 |
| A Pilot Study of Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in Generalized Myasthenia Gravis (NCT01555580) | Muscular Dystrophy Association | 2012-04-01 |
| Perception and Multisensory Integration in Neurological Patients Using fMRI (NCT01469858) | Hadassah Medical Organization | 2011-11-01 |
| Subcutaneous Ig Maintenance Therapy for Myasthenia Gravis (NCT01828294) | St. Louis University | 2011-10-01 |
| A Study to Compare the Efficacy and Safety of Tacrolimus Capsules in Patient With Myasthenia Gravis (NCT01325571) | Astellas Pharma Inc | 2011-03-01 |
| Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford (NCT01793168) | Sanford Health | 2010-07-01 |
| Study of an Intervention to Improve Problem List Accuracy and Use (NCT01105923) | Brigham and Women's Hospital | 2010-05-01 |
| Exercise for Stable Myasthenia Gravis (NCT01047761) | Baltimore VA Medical Center | 2010-01-01 |
| Study Comparing Two Tapering Strategies of Prednisone in Myasthenia Gravis (NCT00987116) | Assistance Publique - Hôpitaux de Paris | 2009-06-01 |
| Trial of Mycophenolic Acid Versus Azathioprine in the Treatment of Corticosteroid-refractory Myasthenia Gravis (NCT00997412) | Qualitix Clinical Research Co., Ltd. | 2009-05-01 |
| Efficacy of Methotrexate in Myasthenia Gravis (NCT00814138) | University of Kansas Medical Center | 2009-04-01 |
| Safety and Efficacy Study of Eculizumab in Patients With Refractory Generalized Myasthenia Gravis (NCT00727194) | Alexion Pharmaceuticals, Inc. | 2008-10-01 |
| Autologous Stem Cell Transplant for Neurologic Autoimmune Diseases (NCT00716066) | Fred Hutchinson Cancer Center | 2008-06-01 |
| Rituximab for the Treatment of Refractory Inflammatory Myopathies and Refractory Myasthenia Gravis (NCT00774462) | Assistance Publique - Hôpitaux de Paris | 2008-01-01 |
| The Role of the Thymus in Myasthenia Gravis (NCT01102192) | Charite University, Berlin, Germany | 2007-08-01 |
| Thymectomy Trial in Non-Thymomatous Myasthenia Gravis Patients Receiving Prednisone Therapy (NCT00294658) | University of Alabama at Birmingham | 2006-06-01 |
| FK506 Phase 3 Study: a Study for Steroid Non-resistant Myasthenia Gravis (MG) Patients (NCT00309088) | Astellas Pharma Inc | 2006-04-01 |
| An Open Study for Steroid Resistant, Non-Thymectomized MG Patients (NCT00309101) | Astellas Pharma Inc | 2006-02-01 |
| Intravenous Immune Globulin Treatment Compared to Placebo in Patients With Myasthenia Gravis (NCT00306033) | University Health Network, Toronto | 2004-03-01 |
| Mycophenolate Mofetil in Myasthenia Gravis (NCT00285350) | FDA Office of Orphan Products Development | 2002-09-01 |
| Hematopoietic Stem Cell Therapy for Patients With Refractory Myasthenia Gravis (NCT00424489) | Northwestern University | 2002-02-01 |
| Serum Auto-Antibodies in Neurological Diseases (NCT00704626) | University of California, Davis | 2002-01-01 |
| Randomized Study of Intravenous Immunoglobulin in Patients With Mild or Moderate Myasthenia Gravis (NCT00004682) | University of Texas | 1995-03-01 |
| Spontaneous Coronary Artery Dissection (SCAD) and Autoimmunity (NCT03941184) | Mayo Clinic | 1995-01-01 |